相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma
E. G. Giannini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Annual Report to the Nation on the Status of Cancer, 1975-2006, Featuring Colorectal Cancer Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates
Brenda K. Edwards et al.
CANCER (2010)
Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma
Katerina Malagari et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Revised Tumor and Node Categorization for Rectal Cancer Based on Surveillance, Epidemiology, and End Results and Rectal Pooled Analysis Outcomes
Leonard L. Gunderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
Hung Huynh et al.
JOURNAL OF HEPATOLOGY (2010)
Rocks Along the Road to the Control of HBV and HCC
R. Palmer Beasley
ANNALS OF EPIDEMIOLOGY (2009)
Prognostic Significance of the DNA-Index in Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis
Sven Jonas et al.
ANNALS OF SURGERY (2009)
Management of Early Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis
Steven C. Cunningham et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Transcriptomic profiling identifies a PU.1 regulatory network in macrophages
Karin Weigelt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
S. J. Schoenleber et al.
BRITISH JOURNAL OF CANCER (2009)
A Comparison of Outcomes From Treating Hepatocellular Carcinoma by Hepatic Artery Embolization in Patients Younger or Older Than 70 Years
Raymond H. Thornton et al.
CANCER (2009)
Metabolic Syndrome and Hepatocellular Carcinoma Two Growing Epidemics With a Potential Link
Abby B. Siegel et al.
CANCER (2009)
Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection
Shu-Chun Chuang et al.
CANCER LETTERS (2009)
(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis
Yohei Shirakami et al.
CANCER SCIENCE (2009)
Gene expression profiling in colorectal cancer using microarray technologies: Results and perspectives
Margherita Nannini et al.
CANCER TREATMENT REVIEWS (2009)
NASH and HCC
John M. Page et al.
CLINICS IN LIVER DISEASE (2009)
Hepatocellular Carcinoma - Epidemiological Trends and Risk Factors
Kerstin Schuette et al.
DIGESTIVE DISEASES (2009)
Factors Associated with Progression to Hepatocellular Carcinoma and to Death from Liver Complications in Patients with HBsAg-Positive Cirrhosis
Myron John Tong et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients
Inyoung Song et al.
EUROPEAN RADIOLOGY (2009)
Early development of sunitinib in hepatocellular carcinoma
Andrew X. Zhu et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
mTOR inhibitors for hepatocellular cancer: a forward-moving target
Gerhard Treiber
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab
Richard S. Finn et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Epidemiology of Hepatitis B in the United States
W. Ray Kim
HEPATOLOGY (2009)
High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection
Jie Hu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma
Melanie B. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
Andrew X. Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Mei-Hwei Chang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
Sandrine Faivre et al.
LANCET ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Management of advanced hepatocellular carcinoma in the era of targeted therapy
Thomas Yau et al.
LIVER INTERNATIONAL (2009)
Recurrence of Hepatocellular Carcinoma and Hepatitis B Reinfection in Hepatitis B Surface Antigen-Positive Patients After Liver Transplantation
Sammy Saab et al.
LIVER TRANSPLANTATION (2009)
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Robert C. Kane et al.
ONCOLOGIST (2009)
Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival
Martin Palavecino et al.
SURGERY (2009)
Survival of patients with hepatocellular carcinoma in cirrhosis:: a comparison of BCLC, CLIP and GRETCH staging systems
C. Camma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents
M. Chaparro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Prognosis of advanced hepatocellular carcinoma:: comparison of three staging systems in two French clinical trials
S. Collette et al.
ANNALS OF ONCOLOGY (2008)
Treatment before liver transplantation for HCC
J. Belghiti et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation
Jason T. Heckman et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Recurrence of hepatocellular carcinoma following liver transplantation - A review of preoperative and postoperative prognostic indicators
Michael A. Zimmerman et al.
ARCHIVES OF SURGERY (2008)
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma
Andrew X. Zhu
CANCER (2008)
Bridge treatments of hepatocellular carcinoma in cirrhotic patients submitted to liver transplantation
Maurizio Pompili et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging
Rieko Shinmura et al.
EUROPEAN RADIOLOGY (2008)
TACE versus TAE as therapy for hepatocellular carcinoma
Maria Pleguezuelo et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma
Yan-Dan Zhong et al.
HEPATOLOGY (2008)
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity
Nilofer S. Azad et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
Abby B. Siegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Detection of Hypervascular Hepatocellular Carcinoma With Multidetector-Row CT: Single Arterial-Phase Imaging With Computer-Assisted Automatic Bolus-Tracking Technique Compared With Double Arterial-Phase Imaging
Takatoshi Kitamura et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2008)
Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI
Wenping Lu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
Hung Huynh et al.
JOURNAL OF HEPATOLOGY (2008)
Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters
Mitsuro Kanda et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma
Clifford S. Cho et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma
Mauricio Silva et al.
LIVER TRANSPLANTATION (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Imaging of Hepatocellular Carcinoma: Qualitative and Quantitative Analysis of Postvascular Phase Contrast-Enhanced Ultrasonography with Sonazoid
Tatsuo Inoue et al.
ONCOLOGY (2008)
Magnetic Resonance Imaging of Hepatocellular Carcinoma Using Contrast Media
Myeong-Jin Kim et al.
ONCOLOGY (2008)
Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer
Michael Hoepfner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
The Impact of New Data in the Treatment of Advanced Hepatocellular Carcinoma
Ghassan K. Abou-Alfa et al.
CURRENT ONCOLOGY REPORTS (2008)
Exploiting novel molecular targets in gastrointestinal cancers
Wen W. Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: An analysis of 293 patients
Kojiro Taura et al.
SURGERY (2007)
Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma
Charles E. Woodall et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Liver resections for hepatocellular carcinoma in chronic liver disease: Experience in an Italian centre
G. Nuzzo et al.
EJSO (2007)
An analysis of resection vs transplantation for early hepatocellular carcinoma: Defining the optimal therapy at a single institution
Shimul A. Shah et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma
Melanie B. Thomas et al.
CANCER (2007)
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma
Chi-Lai Ho et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies
Laura Marelli et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2007)
Referrals for surgical therapy in patients with hepatocellular carcinoma: A community experience
Thomas S. Helling et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2007)
Living donor liver transplantation for patients with HCC exceeding the Milan criteria: A proposal of expanded criteria
Yasutsugu Takada et al.
DIGESTIVE DISEASES (2007)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization
Christos S. Georgiades et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2006)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma
Iwao Ikai et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients
Ning Ren et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis
Alessandro Cucchetti et al.
LIVER TRANSPLANTATION (2006)
RECIST revisited: A review of validation studies on tumour assessment
P. Therasse et al.
EUROPEAN JOURNAL OF CANCER (2006)
Hepatitis B virus-related cirrhosis: Natural history and treatment
CM Chu et al.
SEMINARS IN LIVER DISEASE (2006)
Functional genomics of hepatocellular carcinoma
SS Thorgeirsson et al.
HEPATOLOGY (2006)
Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality
SH Teh et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Hepatic arterial chemoembolization for hepatocellular carcinoma: Comparison of survival rates with different embolic agents
DB Brown et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2005)
Staging and current treatment of hepatocellular carcinoma
HP Clark et al.
RADIOGRAPHICS (2005)
Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer
PA Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Trends in the leading causes of death in the United States, 1970-2002
A Jemal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma:: A case-controlled study
M Biselli et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less
SM Lin et al.
GUT (2005)
Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy
H Tokita et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function
SN Hong et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
PPAR gamma staining as a surrogate for PAX8/PPAR gamma fusion oncogene expression in follicular neoplasms: Clinicopathological correlation and histopathological diagnostic value
M Sahin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy
A Nanashima et al.
EJSO (2004)
Chemoembolization for hepatocellular carcinoma
J Bruix et al.
GASTROENTEROLOGY (2004)
Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD
PH Hayashi et al.
LIVER TRANSPLANTATION (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Predictors and patterns of recurrence after resection of hepatocellular carcinoma
C Cha et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2003)
Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting list
FY Yao et al.
LIVER TRANSPLANTATION (2002)
Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria
FY Yao et al.
LIVER TRANSPLANTATION (2002)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Simplified staging for hepatocellular carcinoma
JN Vauthey et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the Liver Italian Program staging system - A study based on 926 patients
TWT Leung et al.
CANCER (2002)
Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function - Implications for a strategy of salvage transplantation
RTP Poon et al.
ANNALS OF SURGERY (2002)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
分享论文
